ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1429	National Cancer Institute	Html	en	Neuroblastoma Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for neuroblastoma.	cancer treatment 0.486632 cancer screening methods 0.582299 ongoing clinical trials 0.502871 neuroblastoma 0.698844 PDQ cancer information 0.80843 false-negative test result 0.502128 NCI Web site 0.507263 clinical trials 0.709878 vanillyl mandelic acid 0.576656 test result 0.623055 nerve tissue 0.489507 cancer information summary 0.657568 clinical trial 0.522829 breast cancer prevention 0.512391 diagnostic tests 0.506931 test results 0.491146 false-positive test result 0.501632 PDQ summaries 0.524226 latest published information 0.506403 PDQ® Screening 0.491512 NCI’s PDQ 0.527909 cancer symptoms 0.501892 NCI PDQ cancer 0.598105 PDQ Neuroblastoma Screening 0.65982	tests 0.548148 routine screening test 0.556554 Neuroblastoma Treatment 0.531296 new cases 0.489109 PDQ Screening 0.567089 screening tests 0.516882 homovanillic acid 0.494688 Cancer Information Service 0.531924 urine test result 0.504837 Prevention Editorial Board 0.562279 treatment clinical trials 0.501764 National Cancer Institute 0.643496 PDQ documents 0.515811 new treatment 0.51605 health professional version 0.484258 Cancer screening trials 0.58895 PDQ database 0.522175 Cancer Care page 0.516301 adrenal glands 0.539844 PDQ summary 0.591543 cancer information summaries 0.540208 health professional versions 0.487782 comprehensive cancer information 0.541053 cancer 0.90999	CLICK HERE
1530	National Cancer Institute	Html	en	Breast Cancer Treatment and Pregnancy (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of breast cancer during pregnancy.	malignant tumor cells 0.285702 cancer treatment 0.279542 Clinical breast exam 0.313103 breast duct 0.288881 cancer spreads 0.285085 body 0.354774 PDQ cancer information 0.333868 Institute about breast 0.283315 pregnant women 0.305582 late-stage breast cancer 0.332836 lymph nodes 0.53681 breast cancer stage 0.351953 early-stage breast cancer 0.346493 cancer information summary 0.311486 breast cancer prevention 0.334486 pregnancy 0.271424 lymph node biopsy 0.363846 sentinel lymph node 0.409365 diagnose breast cancer 0.392706 NCI PDQ cancer 0.277946 breast carcinoma 0.289316 radiation therapy 0.368972 metastatic breast cancer 0.342784 breast exams 0.330349	general cancer information 0.271263 unborn baby 0.436595 treatment 0.333609 cancer cells 0.52401 Cancer Information Service 0.273422 National Cancer Institute 0.349766 breast changes 0.297373 lymph vessels 0.353177 breast cancer cells 0.386076 stage II breast 0.308585 abnormal cells 0.269332 PDQ Breast Cancer 0.345768 breast cancer 0.954839 breast milk 0.311362 nuclear magnetic resonance 0.266972 IIIC breast cancer 0.337571 inflammatory breast cancer 0.402219 tumor 0.307972 high-energy sound waves 0.266546 treatment options 0.276108 cancer information summaries 0.271389 comprehensive cancer information 0.271648 clinical breast exams 0.312818 lymph ducts 0.27402	CLICK HERE
1579	National Cancer Institute	Html	en	Skin Cancer Treatment (PDQ®)–Patient Version	Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common types of skin cancer. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for skin cancer.	general cancer information 0.204481 skin cancer 0.746718 treatment 0.471679 cancer treatment 0.302297 new cancer treatments 0.201272 NCI-supported cancer 0.203834 cancer cells 0.430807 cancer spreads 0.213207 body 0.317841 type 0.211396 actinic keratosis 0.536665 Cancer Information Service 0.206951 PDQ cancer information 0.297384 Mohs micrographic surgery 0.232682 clinical trial search 0.229474 nonmelanoma skin cancers 0.227999 treatment clinical trials 0.229958 National Cancer Institute 0.31726 clinical trials 0.638709 nearby lymph nodes 0.200291	cancer information summary 0.262865 clinical trial 0.388191 new treatment 0.294947 Skin Cancer Treatment 0.245684 abnormal cells 0.206059 metastatic skin cancer 0.238791 metastatic tumor 0.203344 NCI PDQ cancer 0.214553 Treatment Option Overview 0.208332 cancer clinical trials 0.26868 stage 0.23544 tumor 0.379395 lymph node 0.25053 radiation therapy 0.273121 cancer information summaries 0.204643 nonmelanoma skin cancer 0.66985 comprehensive cancer information 0.204409 basal cell carcinoma 0.71551 cancer 0.986958 information 0.320731	CLICK HERE
1607	National Cancer Institute	Html	en	Levels of Evidence for Cancer Screening and Prevention Studies (PDQ®)–Health Professional Version	Information about how to weigh the strength of the evidence obtained in cancer screening and prevention research studies.	highly selected populations 0.401378 evidence 0.991311 health problem 0.419092 ovarian cancer results 0.40408 PDQ cancer information 0.513684 preventive service 0.422639 PDQ information 0.400135 harms 0.473049 PDQ Editorial Board 0.641716 cancer information summary 0.473744 breast cancer prevention 0.40374 overall mortality reduction 0.492575 potential benefits 0.414509 level 0.4235 evidence support 0.537413 overall evidence 0.50904 NCI’s PDQ 0.403183 quality 0.384284 NCI PDQ cancer 0.45235 reduced usual activity 0.399404 mortality effect 0.425411 intervention 0.453795 health effects 0.479173 Editorial Board 0.827603	benefits 0.440799 clear determination 0.42011 all-cause mortality question 0.432333 general population 0.48479 potential harms 0.397031 conceptual confidence interval 0.402548 health important degree 0.511077 actual evidence 0.562605 specific harms 0.394046 National Cancer Institute 0.475921 magnitude 0.455969 important health effects 0.420577 reasonably certain estimate 0.435178 PDQ documents 0.402929 pdq screening 0.511986 public health 0.419028 direction 0.390004 actual health impact 0.418321 question 0.457086 indirect evidence 0.492584 disease-specific reduction 0.408785 Prevention Editorial Board 0.514271 Alternative format 0.424205 efficacy evidence 0.51812	CLICK HERE
1749	National Cancer Institute	Html	en	Helicobacter pylori and Cancer	A fact sheet about the relationship between H. pylori infection and gastric cancer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and other cancers.	gastric malt lymphoma 0.326658 M. Gastric cancer 0.212884 H. pylori 0.843788 H. pylori colonization 0.258268 gastric cancer rates 0.221795 cagA-negative H. pylori 0.255803 Helicobacter pylori infection 0.310803 gastric adenocarcinoma 0.207225 Helicobacter pylori 0.602968 F. Helicobacter pylori 0.25223 noncardia gastric cancer 0.213325 non-cardia gastric cancer 0.587912	H. pylori infection 0.660511 caga-positive h. pylori 0.364356 gastric cancer 0.957743 M. Helicobacter pylori 0.251667 Helicobacter pylori CagA 0.252645 Helicobacter pylori seropositivity 0.402047 gastric cancer incidence 0.328991 Overall gastric cancer 0.233481 esophageal adenocarcinoma 0.208828 et al 0.379167 pylori infection rates 0.297929 gastric cardia cancer 0.470154	CLICK HERE
1860	National Cancer Institute	Html	es	Tratamiento del cáncer de laringe (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de laringe.	quimioterapia simultánea vs 0.243512 Long-term results 0.234954 radioterapia quizás 0.299585 Zhang Q 0.273545 T4b Enfermedad 0.236466 locally advanced larynx 0.275768 American Cancer Society 0.251609 Pfister DG 0.231071 laringectomía supraglótica 0.243655 Laryngeal Cancer Study 0.26012 nonsurgical treatment 0.254566 laryngeal cancer 0.299143 carcinoma among adult 0.240831 Radiat Oncol Biol 0.820998 DeVita VT Jr 0.253188 glottic larynx treated 0.257222 randomized trial comparing 0.232167 Forastiere AA 0.248924 radiation therapy 0.367315 Head Neck Surg 0.26729 Mendenhall WM 0.301851 with radiotherapy 0.237817 Head Neck 0.3155 cartílago tiroides 0.252905 squamous-cell carcinoma 0.25702	Pajak TF 0.243693 laryngeal carcinoma 0.232948 laringe t1 0.234844 radioterapia posoperatoria 0.379297 Otolaryngol Head Neck 0.267871 múltiples ganglios 0.238357 induction chemotherapy followed 0.233331 local control 0.243042 Clin Oncol 0.490486 Werning JW 0.23125 Oncol Biol Phys 0.857199 glottic carcinoma 0.24993 trial comparing 0.233043 versus concurrent chemoradiotherapy 0.238876 estadio iii 0.267441 neck cancer 0.97371 with or without 0.274489 ganglios linfáticos retrofaríngeos 0.238975 glottic carcinoma among 0.246513 locally advanced 0.370885 Cancer Study Group 0.254186 induction chemotherapy 0.25147 neck carcinoma 0.234046 squamous cell carcinoma 0.852023	CLICK HERE
1968	National Cancer Institute	Html	es	Tratamiento del cáncer escamoso metastásico de cuello con tumor primario oculto (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer escamoso metastásico de cuello con tumor primario oculto.	PDQ Tratamiento 0.637237 glándula tiroides 0.630286 tratamiento.Ciertas formas 0.62926 siguientes procedimientos 0.80319 alta potencia 0.638988 presente sección 0.626186 Physician Data Query 0.682277 rayos x 0.641083 pequeñas marcas 0.628464	cáncer.ampliar radioterapia 0.682908 siguientes enlaces 0.620289 vías respiratorias 0.946667 National Cancer Institute 0.61827 siguientes riesgos 0.612805 siguientes pruebas 0.658061 Instituto Nacional 0.682711 hormonas tiroideas 0.630783 malla ayuda 0.628658	CLICK HERE
3458	National Cancer Institute	Html	es	Aromaterapia y aceites esenciales (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del uso de la aromaterapia y los aceites esenciales para mejorar la calidad de vida de los pacientes de cáncer.	QueaseEaseâ„¢ essential oil 0.322888 Palliat Nurs 0.354113 with dementia 0.319927 Using aromatherapy 0.319114 Adv Nurs 0.330674 aromatherapy massage benefit 0.323369 aromatherapy massage 0.460246 aceite portador 0.411771 effects upon inhalation 0.330851 with sedative effects 0.339649 Essential oils as 0.328315 essential oils with 0.364947 sedative effects upon 0.328613 Estados Unidos 0.358013 Wilkinson S 0.324749 Complement Ther Nurs 0.326064 Ther Nurs Midwifery 0.325274 An evaluation 0.330236 essential oil against 0.321713 Inhalation aromatherapy during 0.319826 patients with 0.403468 essential oil from 0.322691 lavandula vera dc 0.321359 randomized controlled 0.329336 essential oils 0.975981	malignant brain tumours 0.320542 Altern Complement Med 0.328888 wound care 0.337271 células madre 0.337232 contact dermatitis from 0.318516 Essential Oil Therapeutics 0.348142 frecuencia escogen aceites 0.330608 palliative care 0.34198 using essential oils 0.330409 Antibacterial essential oils 0.327832 New York 0.317733 Fragrance compounds 0.318588 Lavandula angustifolia 0.324093 Palliat Med 0.41168 Inhalation aromatherapy 0.326733 verdaderos aceites 0.357046 Van Toller S 0.322917 lavandula angustifolia miller 0.322367 Reino Unido 0.345706 from essential oils 0.326193 Aromatherapy as 0.327736 Essential Oil Blends 0.324181 oils with sedative 0.344081 Dodd GH 0.321815	CLICK HERE
3681	National Cancer Institute	Html	en	Shared Decision Making to Improve Cancer Screening Choices	A research update article about helping patients make informed decisions about cancer screening that reflect their own values and preferences.	decision making tools 0.564345 lung cancer screening 0.788029 professional medical societies 0.349083 Dr. Hersch 0.418291 screening tool 0.396436 Dr. Schonberg 0.35062 patient decision 0.39563 lung cancer 0.926833 Dr. Brito 0.420023 American Cancer Society 0.414855 intervention group 0.401789 mammography—can help women 0.359478 colorectal cancer screening 0.504405 women ages 0.499543 Lung Screening Trial 0.483878 critical medical decisions 0.35192 mammography decision 0.416611 cancer screening options 0.552843 thyroid cancer patients 0.427866 decision tool 0.475317 Affordable Care Act 0.344128 primary care physicians 0.3485 decision tools 0.487153 frequently conflicting guidelines 0.348018 decision making 0.999703	randomized clinical trials 0.355591 benefits 0.348164 cancer screening 0.893329 U.S. Preventive Services 0.345969 United States 0.344585 low-dose helical CT 0.415931 certain screening tests 0.447569 thyroid cancer 0.603366 page written decision 0.429148 screen-detected thyroid cancer 0.405636 decision aid 0.51224 potential harms 0.374261 percent 0.426883 small papillary tumors 0.425086 small thyroid cancer 0.403305 false-positive test results 0.342453 breast cancer screening 0.637919 overdiagnosis 0.377801 lung cancer risk 0.479515 single screening item 0.430742 lung cancer mortality 0.42535 small papillary thyroid 0.358337 reasonable treatment options 0.345648 self-reported decision making 0.430899	CLICK HERE
4249	National Cancer Institute	Html	en	Vaccine Therapy for Unresectable Chordoma	In this phase II clinical trial, adult patients with inoperable chordoma who are scheduled to undergo radiation therapy will be randomly assigned to receive a yeast-based vaccine that targets a protein called brachyury or a placebo injection.	cancer vaccine 0.534872 normal adult tissue 0.528641 immune cell 0.47865 nonirradiated tumors 0.477218 overall response rate 0.514452 yeast cells 0.658954 Locally Advanced Chordoma 0.746841 targets brachyury 0.477414 chordoma 0.972044 tumor behavior 0.49462 adjuvant radiation therapy 0.576614 notochord cells 0.571698 small amounts 0.473793 radiation therapy 0.780229 brachyury vaccine 0.530311 tumor types 0.495175 NCI Center 0.485799 spine forms 0.477842 unresectable localized chordoma 0.680351 unresectable chordoma 0.714897 human brachyury protein 0.536106 experimental vaccine 0.525401 trial contact information 0.525243 United States 0.477985 Dr. Christopher Heery 0.538194	unirradiated tumor 0.498179 Drug Administration 0.474087 cancer cells 0.605559 irradiated tumor 0.517748 chordoma cells 0.729894 Treating Patients 0.48917 main treatment 0.476402 embryonic cells 0.554159 NCI Clinical Trials 0.525164 normal adult cells 0.609554 irradiated tumors 0.540538 tumor growth 0.505122 Cancer Research 0.485391 tumor cells 0.567871 Dr. Heery 0.484528 rare type 0.476522 chordoma patients 0.695766 chordoma tumors 0.646987 Chordoma Foundation 0.62992 yeast-brachyury vaccine 0.59967 Dendritic cells 0.55211 immune cells 0.606104 vaccine 0.650607 principal investigator 0.554808	CLICK HERE